01
Policy favorable to the development of the industry
Since the beginning of the year 2020, the outbreak of the new Crown Pneumonia epidemic at home and abroad, exposing the shortcomings of countries around the globe in the area of public **** health and epidemic prevention and control.
Since the outbreak, governments and related companies have increased investment in research and development of related drugs and vaccines, and conducted various scientific studies and clinical trials.
It is expected that the government will continue to encourage all sectors of society to conduct basic research on C pneumonia and other infectious diseases, and the investment in drug and vaccine research and development will continue to increase, as well as the research and development of testing equipment and reagents for all types of diseases will also be emphasized.
Biological reagents and technical services industry for the above basic research and applied research to provide tools and support, will also continue to benefit.
02
High-skilled personnel training to promote the development of the industry
The research and development and production of biological reagents is a technology-intensive industry, which requires a high level of specialization in the level of knowledge.
In the past few years, China's education level has improved to promote the cultivation of high-quality talents in related fields, and the rapid growth of talents in life sciences and bio-engineering disciplines has sent a large number of talents to the industry and enterprises, which has boosted the research and development efficiency and quality of the bio-reagent industry.
03
Biopharmaceutical industry R & D investment efforts to promote industry progress
Under the influence of unhealthy lifestyles, environmental pollution, population aging and other factors, the global tumor, diabetes and other disease groups continue to expand.
At the same time, the application of biomolecule drugs represented by monoclonal antibodies in diagnosis and disease treatment is gradually increasing, and the promotion of clinical diagnostic methods such as antibody-based immunodiagnostics plays an important role in detecting diseases in advance, and reduces the medical burden of patients and society as a whole;
And biologic drugs, such as monoclonal antibodies, are of great significance in improving therapeutic efficacy and treatment accuracy, and in reducing side-effects of treatment. side effects of treatment.